SHARE SUBSCRIPTION AGREEMENT THIS SHARE SUBSCRIPTION AGREEMENT (the "Agreement") is made on 26 June, 2024
Exhibit 99.1
THIS SHARE SUBSCRIPTION AGREEMENT (the "Agreement") is made on 26 June, 2024
("Effective Date"), between the following parties:
and
(collectively "Parties" and each a "Party").
Subject to the terms and conditions of this Agreement, the Company shall issue to the Subscriber and the Subscriber shall subscribe from the Company, all of the title and interest in and to 6,235,410 (Six
Million Two Hundred Thirty Five Thousand Four Hundred and Ten) ordinary shares of the Company, with the consideration of US$ 1,032,583.89 (i.e. equivalent to JPY 162,662,940 (One Hundred Sixty Two Million Six Hundred Sixty Two Thousand Nine Hundred and Forty Japanese Yen) at the conversion rate of JPY 157.53 per US$ 1.00, which is the TTM exchange rate as of 18 June 2024 by Mitsubishi UFJ Bank), divided by US$ 0.1656/NCNC share, derived from 15% discount from the mid point of 50 business days moving average and 30 business days moving average as of 25 June 2024 (the "Subscription Shares"), together with all rights, dividends, entitlements and benefits now and hereafter attaching thereto, with the consideration and the subscription schedule as set forth in the Exhibit A.
Private and Confidential
As of the date of this Agreement, the Subscriber makes the following representations, warranties and covenants to the Company:
As of the date of this Agreement, the Company makes the following representations, warranties and covenants to the Company:
Private and Confidential
This Agreement constitutes the entire understanding and agreement of the Parties relating to the subject matter of this Agreement, and supersedes all previous oral and written representations, exchanges, understandings and agreements made or reached by and between the Parties up to and including the date of this Agreement. The Parties acknowledge and agree that, in entering into this Agreement, no Party has relied on any representation, warranty or undertaking which is not included in this Agreement.
If any provision of this Agreement shall be illegal, or for any other reason unenforceable, such provision shall be deemed to be independent from the other provisions of this Agreement and shall not affect the effect or enforceability of such other provisions, which shall continue to be effective and enforceable in accordance with their terms.
No Party shall be entitled to assign the benefit of any provision of this Agreement without the prior written approval of the other Party and compliance with the applicable law.
Unless otherwise provided in this Agreement or agreed in writing by the Parties to this Agreement, each Party shall bear its own costs incurred by it in relation to the execution and implementation of this Agreement (including without limitation legal fees).
All notices shall be written in English and may be delivered either by hand, registered airmail or fax to the following addresses or fax numbers (as the case may be):
Future Science Research Inc. (Company Registration Number: 0110-01-098102)
Address: |
Akasaka, Minato-ku, Tokyo, JAPAN |
Phone: |
+8 l-(0)0-0000-0000 |
Fax: |
+8 l-(0)0-0000-0000 |
Email: |
x.xxxxxxxx@x-x-x.xx |
|
|
xxxx-noco Inc. (CUSIP Number G7243Pl09)
Address: |
0 Xxxxxxx Xxx, #00-00 XXX Xxxxxx XX, Xxxxxxxxx 000000 |
Phone: |
x00-(0)00-0000-0000 |
Fax: |
+8 l-(0)0-0000-0000 |
Email: |
xxxxxxx.xx@xxxx-xxxx.xxx |
|
|
Notices shall be deemed to have been delivered at the following times:
Private and Confidential
This Agreement may be entered into in any number of counterparts, all of which taken together shall constitute one and the same original instrument. Any Party may enter into this Agreement by executing any such counterpart.
---- Rest of this page intentionally left blank --------------
Private and Confidential
IN WITNESS whereof the Parties have executed this Agreement on the day and year first above written.
|
|
EXECUTED for and on behalf of |
) |
Future Science Research Inc. |
) Duly Authorised Signatory |
|
) |
|
) Name: Xxxxxx XXXXXXXX |
|
) |
|
) Title: Representative Director |
|
|
|
|
EXECUTED for and on behalf of |
) |
noco-noco Inc |
) Duly Authorised Signatory |
|
) |
|
) Name: Xxxxxxxx XXXXXXXXX |
|
) |
|
) Title: Director and CEO |
|
|
Private and Confidential
EXHIBIT A
Subscriber |
Number of Shares |
Consideration |
Future Science Research Inc. |
6,235,410 Ordinary Shares of the Issuer |
US$ 1,032,583.89 (i.e. equivalent to JPY 162,662,940) |
Private and Confidential